Kim Krogsgaard

4.8k total citations · 1 hit paper
88 papers, 3.6k citations indexed

About

Kim Krogsgaard is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Kim Krogsgaard has authored 88 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 49 papers in Hepatology and 12 papers in Infectious Diseases. Recurrent topics in Kim Krogsgaard's work include Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (43 papers) and Liver Disease Diagnosis and Treatment (31 papers). Kim Krogsgaard is often cited by papers focused on Hepatitis B Virus Studies (43 papers), Hepatitis C virus research (43 papers) and Liver Disease Diagnosis and Treatment (31 papers). Kim Krogsgaard collaborates with scholars based in Denmark, Sweden and United States. Kim Krogsgaard's co-authors include Christian Gluud, Per Hölmich, Jan Aldershvile, P. Wantzin, Peter Kryger, A M Bjerg, Jens Nielsen, Poul Andersson, Inge‐Lis Kanstrup and Michael Bachmann Nielsen and has published in prestigious journals such as The Lancet, PLoS ONE and Hepatology.

In The Last Decade

Kim Krogsgaard

87 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo

2015 379 citations Giuseppe Pantaleo, Kim Krogsgaard et al. profile →

Peers

Countries citing papers authored by Kim Krogsgaard

Since Specialization

Citations

This map shows the geographic impact of Kim Krogsgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Krogsgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Krogsgaard more than expected).

Fields of papers citing papers by Kim Krogsgaard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Krogsgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Krogsgaard. The network helps show where Kim Krogsgaard may publish in the future.

Co-authorship network of co-authors of Kim Krogsgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Krogsgaard. A scholar is included among the top collaborators of Kim Krogsgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Krogsgaard. Kim Krogsgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption 2019 ·PLoS ONE ·Jürgen K. Rockstroh, David M. Asmuth, Giuseppe Pantaleo, Bonaventura Clotet, Daniel Podzamczer, Jan van Lunzen, Keikawus Arastéh, Ronald T. Mitsuyasu, Barry Peters, Silvia Nozza, (unknown), Mats Ökvist, Kim Krogsgaard, Maja A. Sommerfelt	7
2	The effects of the CXCR2 antagonist, MK-7123, on bone marrow functions in healthy subjects 2015 ·Cytokine ·Nina Hastrup, Sauzanne Khalilieh, David C. Dale, Lars G. Hanson, Peter Magnusson, Anjela Tzontcheva, Jack Tseng, Susan Huyck, Elizabeth Rosenberg, Kim Krogsgaard	12
3	N-Terminal proBNP and Mortality in Hospitalised Patients with Heart Failure and Preserved Vs. Reduced Systolic Function: Data from the Prospective Copenhagen Hospital Heart Failure Study (CHHF) 2004 ·European Journal of Heart Failure ·Vibeke Kirk, M. Bay, Jan Parner, Kim Krogsgaard, (unknown), Søren Boesgaard, Christian Hassager, Olav Wendelboe Nielsen, Jan Aldershvile, Henrik Nielsen	83
4	Effects of amiodarone and thoracic epidural analgesia on atrial fibrillation after coronary artery bypass grafting 2004 ·Journal of Cardiothoracic and Vascular Anesthesia ·Eigil Nygård, (unknown), (unknown), Finn Møller Pedersen, Jesper Ravn, Lars Thomassen, Jesper Hastrup Svendsen, K. Eliasen, Kim Krogsgaard, Jan Aldershvile	19
5	Efficacy of Selective Antenatal Screening for Hepatitis B Among Pregnant Women in Denmark: Is Selective Screening Still an Acceptable Strategy in a Low-endemicity Country? 2003 ·Scandinavian Journal of Infectious Diseases ·Lise Heilmann Jensen, Carsten Heilmann, Else Smith, P. Wantzin, Birgit Peitersen, Tom Weber, Kim Krogsgaard	17
6	Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B 2002 ·The Cochrane Database of Systematic Reviews ·(unknown), Kim Krogsgaard, Philippe Mathurin, Christian Gluud, Thierry Poynard	7
7	Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay 2001 ·Journal of Viral Hepatitis ·Magnus Lindh, Charles Hannoun, Peter Horal, Kim Krogsgaard, (unknown)	7
8	A Randomized Trial Assessing the Impact of Written Information on Outpatients' Knowledge About and Attitude Toward Randomized Clinical Trials 2000 ·Controlled Clinical Trials ·(unknown), Lise Lotte Kjaergard, Kim Krogsgaard, Christian Gluud, Erik Lykke Mortensen, Adam Gottschau, A M Bjerg	36
9	[Occurrence of hepatitis B and C among mentally retarded]. 1999 ·PubMed ·(unknown), (unknown), Kim Krogsgaard, N Rosdahl, (unknown), P. Wantzin	6
10	[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]. 1998 ·PubMed ·Kim Krogsgaard, Patrick Marcellin, C. Trépo, P. Berthelot, (unknown), (unknown), Andrew Tran, Denis Ouzan, Helmer Ring‐Larsen, Jens Lindberg, José M. Enríquez–Navascués, Benhamou Jp, Niels Bindslev	2
11	The long‐term effect of treatment with interferon‐α2a in chronic hepatitis B 1998 ·Journal of Viral Hepatitis ·Kim Krogsgaard, (unknown), (unknown)	65
12	Would you trust a surrogate respondent? 1997 ·The Lancet ·Christian Gluud, Kim Krogsgaard	6
13	Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type B 1995 ·Hepatology ·G. Fattovich, G. Giustina, Solko W. Schalm, Stephanos J. Hadziyannis, J.M. Sánchez-Tapias, Piero Luigi Almasio, Erik Christensen, Kim Krogsgaard, Françoise Degos, Miguel Carneiro de Moura, Antonio Solinas, Franco Noventa, G. Realdi	292
14	The treatment effect of alpha interferon in chronic hepatitis B is independent of pre-treatment variables. Results based on individual patient data from 10 clinical controlled trials 1994 ·Journal of Hepatology ·Kim Krogsgaard, (unknown), Niels Bindslev, Erik Christensen, Antonio Craxı̀, P. Schlichting, Solko W. Schalm, Vicente Carréño, C. Trépo, Guido Gerken, Howard C. Thomas, Per Kragh Andersen, Helmer Ring‐Larsen	70
15	Hepatitis C in dialysis patients: Relationship to blood transfusions, dialysis and liver disease 1993 ·Kidney International ·F Knudsen, P. Wantzin, Knud Rasmussen, S. D. Ladefoged, (unknown), Lars S. Rasmussen, (unknown), Kim Krogsgaard	81
16	Sexual transmission of hepatitis C virus: cohort study (1981-9) among European homosexual men. 1990 ·BMJ ·Mads Melbye, Robert J. Biggar, P. Wantzin, Kim Krogsgaard, Peter Ebbesen, Niels G. Becker	124
17	Reactivation of viral replication in anti‐HBe positive chronic HBsAg carriers 1990 ·Liver International ·Kim Krogsgaard, Jan Aldershvile, Peter Kryger, (unknown), Poul Andersson, Henrik Dalbøge, (unknown), (unknown)	9
18	HIV Neutralizing Antibodies: Development and Association with HIV Related Disease 1989 ·Scandinavian Journal of Infectious Diseases ·Maiken Cavling Arendrup, (unknown), Jens Nielsen, Bjarne Ørskov Lindhardt, Philip Kusk, Peter M. H. Heegaard, Court Pedersen, Kim Krogsgaard	4
19	Delta Infection and Hepatitis B Virus Replication in Danish Patients with Fulminant Hepatitis B 1988 ·Scandinavian Journal of Infectious Diseases ·Kim Krogsgaard, Peter M. H. Heegaard, Jan Aldershvile, Peter Kryger, Poul Andersson, B. G. Hansson, Jens Nielsen, L Ranek	6
20	A Prevalence Study of HIV Antibodies in Rural Kenya 1987 ·Scandinavian Journal of Infectious Diseases ·Hans Draminsky Petersen, (unknown), (unknown), (unknown), A. K. Chemtai, Kim Krogsgaard, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact